Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 18.6 kDa. The protein migrates as 19-22 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Canine TNF-alpha, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
The purity of Canine TNF-alpha, His Tag (Cat. No. TNA-C52H3) is more than 90% and the molecular weight of this protein is around 55-65 kDa verified by SEC-MALS.
Immobilized Humira at 5 μg/mL (100 μL/well) can bind Canine TNF-alpha, His Tag (Cat. No. TNA-C52H3) with a linear range of 0.3-1 ng/mL (QC tested).
Immobilized Human TNFR1, Fc Tag (Cat. No. TN1-H5251) at 5 μg/mL (100 μL/well) can bind Canine TNF-alpha, His Tag (Cat. No. TNA-C52H3) with a linear range of 2-10 ng/mL (Routinely tested).
ACROBiosystems는 생체 활성이 높은 균질한 CD3 δ/CD3 ε 및 CD3 γ/CD3 ε 단백질을 개발하여 이중특이 항체를 치료제로의 임상 개발을 가속시킵니다.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
오가노이드 툴 박스는 약물 개발 프로젝트의 진행을 가속할 수 있는 레디메이드 오가노이드와 오가노이드 분화 툴 키트 및 다양한 서비스를 포함하는 오가노이드 솔루션 모음입니다.
고품질 GMP 등급 사이토카인 IL-15,IL-7, IL-21 등 제품은 신속한 임상/신약승인신청을 위해 개발된 것입니다.
50+ car-t의 인기 타겟을 커버하고, car 발현 검사를 위해 특별히 설계된 항원 단백질은 스트림 검증을 통해 고특이성 car 발현을 검출할 수 있으며, 고 배치간 일관성을 가지고 있다.pe/fi표기 단백질로 한 단계 염색하면 고특이성, 무 백그라운드로 car 발현 검사를 검사할 수 있습니다.
cd20, claudin18.2, cd133, gprc5d, ccr5, ccr8을 포함한 안정적이고 활성이 높은 전장 다중 막관통 단백질은 면역, elisa, spr, bli, 세포 실험, car 양성률 검사 등에 광범위하게 사용된다. vlp, 스케일제거제, nanodisc의 다양한 기술 플랫폼은 다중 막관통 단백질을 목표로 하는 약물 연구에 도움을 준다.
GMP 등급 사이토카인. 고품질 세포 활성화 및 확장 시약. 유전자 편집 시약, 효소 CAR 검사 시약 등 제품. 세포 및 유전자 요법 고객님에게 포괄적인 솔루션을 제공하고 초기 약물 발견에서 임상 연구에 이르기까지 모든 단계에서 귀하와 동반하겠습니다.
현재 이미 알려진 거의 대부분의 면역 체크 포인트 분자를 포함하여 다양한 레벨과 물종을 제공하여 고객이 선택할수 있도록 하고있다. 천연중합체 형식은 mals를 통해 검증되었고 생물활성은 elisa/spr/bli/facs 등을 통해 검증되었으며 또한 biotin/fitc 표지는 높은 처리량을 가진 항체를 선별하는데 편리하다.
ACROBiosystems는 ADC약물의 연구개발을 돕기 위해 노력하고 있으며, 다양한 인기 타겟에 서로 다른 종, 다른 라벨의 제품을 개발했으며, 높은 순도, 높은 친화력 등 특징을 가지고 있으며, 면역, 항체 선택, spr, 세포 활성 검사 및 기타 실험에 적합하고, 해당 protocol을 무료로 제공합니다.
Fc 수용체 단백질은 모든 분자를 포함하고 있을 뿐만 아니라, 일반적인 돌연변이와 바이오틴 표기 종류을 포함하고 있어 고객들이 단일 클론 항체 개발을 가속화할 수 있다.
포괄적으로 풍부한 사이토카인 표적 단백질은 HEK293 진핵생물 시스템에 의해 발현되며 천연 구조에 더 가깝다. 고순도는 SDS-PAGE/HPLC/MALS에 의해 검증된다. 높은 생물학적 활성이 ELISA/SPR/BLI에 의해 검증된다. 배치간 일관성이 우수하여 항체 면역, 스크리닝 및 품질 관리 과정에 적합하다.
Aneuro는 ACROBiosystems가 뇌과학 연구에 초점을 맞춘 제품 라인으로서 치료 및 진단 연구 단백질, PFFs와 재조합 신경 인자 등 뇌과학 연구 분야에 중요한 단백질 제품을 제공하여 뇌과학 연구에 도움이 된다.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Etanercept biosimilar (Hanwha Chemical) | HD-203; MK-8953 | Approved | Hanwha Chemical | Davictrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | ||||
Anti-tumour necrosis factor-alpha antibody | Approved | Materia Medica Holding Research And Production Company | Artrofoon, Arthrofoon | Arthritis, Rheumatoid; Osteoarthritis | Details | |||||
Etanercept biosimilar (AryoGen Biopharma) | Approved | Aryogen Biopharma | Altebrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |||||
Adalimumab biosimilar (Reliance Life Sciences) | R-TPR-021 | Approved | Reliance Life Sciences | Adfrar IB | India | Colitis, Ulcerative; Psoriasis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid | Torrent Pharma, Reliance Life Sciences | 2016-01-12 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic | Details |
Certolizumab pegol | PHA-738144; CDP-870; CZP | Approved | Ucb | 希敏佳, Cimzia, Cimziat | United States | Crohn Disease | Ucb Inc | 2008-04-22 | Non-radiographic axial spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis; Infertility, Male; Spondylarthropathies; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Cystitis, Interstitial; Colitis, Ulcerative; Osteoarthritis, Spine; Crohn Disease; Plaque psoriasis | Details |
Etanercept biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Nanercept | Vietnam | Psoriasis; Arthritis, Rheumatoid | Nanogen Biopharmaceutical Co | 2019-01-01 | Arthritis, Rheumatoid; Psoriasis | Details | |
Infliximab Biosimilar (Genor Biopharma) | GB-242 | Approved | Genor Biopharma Co Ltd | 佳佑健 | Mainland China | Spondylitis, Ankylosing; Crohn Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Rheumatoid | Yuxi Genor Biotechnology Co Ltd | 2022-02-23 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Crohn Disease | Details |
Etanercept biosimilar (Mochida) | LBEC-0101 | Approved | Mochida Pharmaceutical Co Ltd | Japan | Arthritis, Juvenile; Arthritis, Rheumatoid | null | 2018-01-19 | Arthritis, Rheumatoid; Arthritis, Juvenile | Details | |
Adalimumab biosimilar (Amgen) | ABP-501 | Approved | Amgen Inc | Amjevita, Amgevita, Solymbic | United States | Colitis, Ulcerative; Crohn Disease; Psoriasis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid | Amgen Inc | 2016-09-23 | Non-radiographic axial spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Pediatric ulcerative colitis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Crohn Disease; Plaque psoriasis | Details |
Etanercept biosimilar (PROBIOMED) | Approved | Probiomed | Infinitam | Mexico | Arthritis, Rheumatoid | Probiomed | 2014-01-01 | Arthritis, Rheumatoid | Details | |
Adalimumab biosimilar (Fresenius Kabi) | MSB-11022 | Approved | Merck Serono, Fresenius Kabi Ag | Idacio, Kromeya | EU | Colitis, Ulcerative; Crohn Disease; Uveitis; Arthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis | Fresenius Kabi Deutschland Gmbh | 2019-04-02 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Hidradenitis Suppurativa; Plaque psoriasis; Crohn Disease | Details |
Etanercept biosimial (Sandoz) | GP-2015 | Approved | Clariant Produkte (Schweiz) Ag | Erelzi | United States | Psoriasis; Arthritis, Juvenile; Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing | Sandoz | 2016-08-30 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
Adalimumab biosimilar (Sinocelltech) | SCT-630 | Approved | SinoCelltech Ltd | 安佳润 | Mainland China | Psoriasis; Arthritis, Juvenile; Uveitis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Crohn Disease; Pediatric Crohn's disease | SinoCelltech Ltd | 2023-06-07 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Uveitis; Plaque psoriasis; Crohn Disease | Details |
Lenalidomide | CC-5013; IMiD-3; ENMD-0997; STAR-LLD; IMID-5013; CDC-5013; CDC-501 | Approved | Celgene Corp | Revimid (former Brand Name), 瑞复美, Revlimid, Leavdo, Zelvina | United States | Myelodysplastic Syndromes | Bristol Myers Squibb Srlcompany | 2005-12-27 | Lymphoma, T-Cell, Peripheral; Lymphoma, B-Cell, Marginal Zone; Solid tumours; Bone Marrow Neoplasms; Kidney Neoplasms; Leukemia, Myeloid; Leukemia; Intestinal Neoplasms; Craniopharyngioma; Optic Nerve Glioma; Leukemia, Promyelocytic, Acute; Ovarian Neoplasms; Medulloblastoma; Ependymoma; Immunoproliferative Small Intestinal Disease; Leukemia, Erythroblastic, Acute; Hematologic Diseases; Liver Neoplasms; Plaque, Amyloid; Anemia; Pain; Paraproteinemias; Polycythemia Vera; Anemia, Refractory, with Excess of Blasts; Rhabdoid Tumor; Leukemia, Hairy Cell; Lymphoma, Large B-Cell, Diffuse; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia-Lymphoma, Adult T-Cell; Plasmacytoma; Hodgkin Disease; Graft vs Host Disease; Glioblastoma; Neoplasms; Blood Protein Disorders; Nerve Degeneration; Anemia, Refractory; Hypothalamic Neoplasms; Leukemia, Myelomonocytic, Acute; Pancreatic Neoplasms; Lymphomatoid Granulomatosis; Smoldering Multiple Myeloma; Multiple Myeloma; Urinary Bladder Neoplasms; Central Nervou | Details |
Etanercept biosimilar (Amega Biotech) | Approved | Amega Biotech | Enerceptan | Argentina | Arthritis, Rheumatoid | Amega Biotech | 2012-01-01 | Arthritis, Rheumatoid | Details | |
Infliximab biosimilar (Reliance Life Sciences) | BOW-015; R-TPR-015 | Approved | Epirus Biopharmaceuticals Inc | Infimab | Arthritis, Rheumatoid | Details | ||||
Adalimumab biosimilar (Celltrion) | CT-P17 | Approved | Celltrion Inc | Yuflyma | EU | Pediatric Crohn's disease; Spondylitis, Ankylosing; Pediatric ulcerative colitis; Arthritis, Juvenile; Plaque psoriasis; Arthritis, Psoriatic; Psoriasis; Colitis, Ulcerative; Hidradenitis Suppurativa; Arthritis, Rheumatoid; Crohn Disease; Uveitis | Celltrion Healthcare Hungary Kft | 2021-02-11 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Pediatric ulcerative colitis; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis; Crohn Disease | Details |
Etanercept biosimilar (Intas Biopharmaceuticals) | Approved | Intas Biopharmaceuticals | Intacept | India | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Psoriasis | Intas Biopharmaceuticals | 2015-03-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |
Infliximab biosimilar (Amgen) | ABP-710 | Approved | Amgen Inc | Avsola | United States | Pediatric ulcerative colitis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Plaque psoriasis; Colitis, Ulcerative; Crohn Disease; Pediatric Crohn's disease | Amgen Inc | 2019-12-06 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric Crohn's disease; Pediatric ulcerative colitis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease | Details |
Adalimumab biosimilar (Lg Chemical) | LBAL | Approved | Lg Chemical Ltd | Xelenka | Japan | Panuveitis; Colitis, Ulcerative; Crohn Disease; Spondylitis, Ankylosing; Behcet Syndrome; Uveitis, Intermediate; Uveitis, Posterior; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Arthritis, Juvenile | Mochida Pharmaceutical Co Ltd | 2021-03-23 | Non-radiographic axial spondyloarthritis; Uveitis, Intermediate; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Uveitis, Posterior; Panuveitis; Crohn Disease; Behcet Syndrome; Plaque psoriasis | Details |
Adalimumab biosimilar (Boehringer Ingelheim) | BI-695501 | Approved | C.H. Boehringer Sohn Ag & Co. Kg | Cyltezo | United States | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis | Boehringer Ingelheim Gmbh | 2017-08-25 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Crohn Disease | Details |
Golimumab | CNTO-148; rTNV148B | Approved | Johnson & Johnson Innovative Medicine | Simponi/Simponi aria, Simponi, Simponi aria | United States | Spondylitis, Ankylosing; Arthritis, Psoriatic; Arthritis, Rheumatoid | Centocor Ortho Biotech Inc | 2009-04-24 | Non-radiographic axial spondyloarthritis; Diabetes Mellitus, Type 1; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Colitis, Ulcerative; Arthritis, Psoriatic; Asthma; Labyrinth Diseases; Crohn Disease | Details |
Adalimumab biosimilar (Mylan/Biocon) | BMO-2; MYL-1401-A | Approved | Biocon Ltd | United States | Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis | Mylan Pharmaceuticals Inc | 2020-07-06 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Crohn Disease; Plaque psoriasis | Details | |
Luminol sodium | MP-1032 | Approved | Selvim, Metrio | Psoriasis; Immune System Diseases | null | 1997-01-01 | Coronavirus Disease 2019 (COVID-19); Immune System Diseases; Psoriasis; Plaque psoriasis | Details | ||
Adalimumab biosimilar (Innovent Biologics) | IBI-303 | Approved | Innovent Biologics(Suzhou) Co Ltd | 苏立信 | Mainland China | Psoriasis; Spondylitis, Ankylosing; Arthritis, Rheumatoid | Innovent Biologics(Suzhou) Co Ltd | 2020-09-02 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Uveitis; Plaque psoriasis; Crohn Disease | Details |
Infliximab biosimilar (Pfizer) | PF-6438179; GP-1111; PF-06438179 | Approved | Pfizer Inc | Ixifi, Zessly | EU | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric Crohn's disease; Pediatric ulcerative colitis; Colitis, Ulcerative; Crohn Disease; Psoriasis; Arthritis, Psoriatic | Pfizer Europe Ma Eeig | 2013-09-09 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric Crohn's disease; Pediatric ulcerative colitis; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis; Crohn Disease | Details |
Adalimumab biosimilar (Bio-Thera Solutions) | BAT-1406 | Approved | Bio-Thera Solutions Ltd | 格乐立 | Mainland China | Arthritis, Rheumatoid; Crohn Disease; Uveitis; Spondylitis, Ankylosing; Psoriasis | Bio-Thera Solutions Ltd | 2019-11-04 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Uveitis; Crohn Disease | Details |
Adalimumab biosimilar (Alvotech) | AVT-02 (Alvotech) | Approved | Alvotech hf | SIMLANDI, Ardalicip, Ciptunec, HUKYNDRA, LIBMYRIS | EU | Uveitis; Hidradenitis Suppurativa; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Crohn Disease; Psoriasis; Colitis, Ulcerative | Stada Arzneimittel Ag | 2021-11-12 | Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Hidradenitis Suppurativa; Inflammation; Plaque psoriasis; Crohn Disease | Details |
Adalimumab biosimilar (Biocad) | BCD-057 | Approved | BIOCAD JSC | Russian Federation | Psoriasis | BIOCAD JSC | 2019-03-01 | Psoriasis | Details | |
Adalimumab biosimilar (Shanghai Henlius Biotech) | HLX-03 | Approved | Shanghai Henlius Biotech Inc | 汉达远 | Mainland China | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis | Shanghai Henlius Biotech Inc | 2020-12-02 | Uveitis, Intermediate; Pediatric Crohn's disease; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Immune System Diseases; Psoriasis; Uveitis, Posterior; Plaque psoriasis; Crohn Disease; Panuveitis | Details |
Infliximab | TA-650 | Approved | Johnson & Johnson Innovative Medicine | Remicade, 类克, Avakine, CenTNF | United States | Crohn Disease | Centocor | 1998-08-24 | Pulmonary Disease, Chronic Obstructive; Pediatric ulcerative colitis; Glaucoma; Diabetic macular oedema; Visual Acuity; Vitreoretinopathy, Proliferative; Arthritis, Psoriatic; Colitis, Ulcerative; Parapsoriasis; Aneurysm; Retinal Detachment; Psoriasis; Granulomatous Disease, Chronic; Hidradenitis Suppurativa; Uveitis; Crohn Disease; Plaque psoriasis; Behcet Syndrome; Melanoma; Diabetic Retinopathy; Stevens-Johnson Syndrome; Spondylitis, Ankylosing; Non-radiographic axial spondyloarthritis; Pancreatitis; Dermatomyositis; Giant Cell Arteritis; Inflammatory Bowel Diseases; Scleritis; Macular Edema; Graft vs Host Disease; Pediatric Crohn's disease; Arthritis, Rheumatoid; Polymyositis; Sarcoidosis; Coronavirus Disease 2019 (COVID-19); Vasculitis; Spondylarthropathies; Bipolar Disorder; Mucocutaneous Lymph Node Syndrome; Arthritis, Juvenile; Stroke; Polymyalgia Rheumatica | Details |
Infliximab biosimilar (Shanghai Biomabs) | STI-002; CMAB-008 | Approved | Shanghai Biomabs Pharmaceuticals Co Ltd | 百类停, 类停 | Mainland China | Crohn Disease; Colitis, Ulcerative; Spondylitis, Ankylosing; Pediatric Crohn's disease; Psoriasis; Arthritis, Rheumatoid | Taizhou Mabtech Pharmaceutical Co Ltd | 2021-07-12 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Psoriasis; Colitis, Ulcerative; Crohn Disease | Details |
Infliximab biosimilar (Hisun Pharma) | HS-626 | Approved | Zhejiang Hisun Pharmaceutical Co Ltd | Mainland China | Psoriasis | Hisun Biopharmaceutical Co Ltd | 2021-09-24 | Psoriasis | Details | |
Infliximab biosimilar (Bionovis/The Instituto Vital Brazil) | Approved | Bionovis, The Instituto Vital Brazil | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details | ||||||
Etanercept biosimilar (Mylan) | YLB-113 | Approved | Lupin Ltd, Mylan Nv | Nepexto | EU | Spondylarthropathies; Spondylitis, Ankylosing; Arthritis, Psoriatic; Arthritis, Juvenile; Arthritis, Rheumatoid; Plaque psoriasis | Biosimilar Collaborations Ireland Ltd | 2020-05-20 | Spondylarthropathies; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Arthritis, Psoriatic; Plaque psoriasis | Details |
Pomalidomide | CDC-394; CC-4047; IMiD-1; IMID-4047 | Approved | Celgene Corp | Pomalyst, Imnovid, Actimid, Pomalyst/Imnovid, 安跃 | United States | Multiple Myeloma | Bristol-Myers Squibb Company | 2013-02-08 | Lung Diseases, Interstitial; Neurofibromatosis 1; Atypical Squamous Cells of the Cervix; Sarcoma, Kaposi; Anemia, Sickle Cell; Lymphoma, Non-Hodgkin; Carcinoma, Small Cell; Glioma; Waldenstrom Macroglobulinemia; Primary Myelofibrosis; Prostatic Neoplasms; Thrombocytosis; Sarcoma; Central Nervous System Neoplasms; Pulmonary Fibrosis; Medulloblastoma; Multiple Myeloma; Pancreatic Neoplasms; Hodgkin Disease; Plasmacytoma; Myeloproliferative Disorders; Immunoglobulin Light-chain Amyloidosis; Graft vs Host Disease; Scleroderma, Systemic; Renal Insufficiency; Polycythemia Vera; Bone Marrow Neoplasms; Solid tumours; Optic Nerve Glioma | Details |
Adalimumab biosimilar (Jiangsu Zhonghe/Shanghai Junshi/Jiangsu T-Mab) | 9MW-0113; 9MW0113; UBP-1211; 9-MW-0113; 9-MW0113 | Approved | Shanghai Junshi Biosciences Co Ltd, Jiangsu Zhonghe Pharmaceutical Technology Co Ltd, Jiangsu T-Mab Bio-Pharmaceuticals Co Ltd, Mabwell (Shanghai) Bioscience Co Ltd | 君迈康 | Mainland China | Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing | Shanghai Junshi Biosciences Co Ltd | 2022-03-01 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Uveitis; Crohn Disease | Details |
Adalimumab biosimilar (Samsung Bioepis) | SB-5 | Approved | Samsung Bioepis Co Ltd | Imraldi, Hadlima | EU | Pediatric Crohn's disease; Arthritis, Juvenile; Plaque psoriasis; Psoriasis; Pediatric ulcerative colitis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Hidradenitis Suppurativa; Uveitis | Samsung Bioepis Nl Bv | 2017-08-24 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Pediatric ulcerative colitis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Plaque psoriasis; Crohn Disease | Details |
Adalimumab biosimilar (Fujifilm Kyowa Kirin Biologics/Mylan) | FKB-327 | Approved | Fujifilm Kyowa Kirin Biologics Co Ltd | Hulio | EU | Arthritis, Psoriatic; Hidradenitis Suppurativa; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Uveitis; Colitis, Ulcerative; Crohn Disease | Biosimilar Collaborations Ireland Ltd | 2018-09-16 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Crohn Disease | Details |
Etanercept biosimilar (Sunshine Guojian) | 301S | Approved | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd, Cipla Gmbh | Yisaipu, 益赛普, Etanar, Etacept | Mainland China | Arthritis, Rheumatoid; Psoriasis; Spondylitis, Ankylosing | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | 2005-06-20 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details |
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis, Knee; Osteoarthritis | Details |
Adalimumab biosimilar (Sandoz) | GP-2017 | Approved | Sandoz | Hefiya, Hyrimoz, Halimatoz | EU | Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Plaque psoriasis; Colitis, Ulcerative; Crohn Disease; Polyarticular Juvenile Idiopathic Arthritis; Non-radiographic axial spondyloarthritis; Hidradenitis Suppurativa | Sandoz Gmbh | 2018-07-26 | Non-radiographic axial spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Plaque psoriasis; Crohn Disease | Details |
Edaravone/(+)-2-Decanol | SIM-071201 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | 三贝心, 三贝欣, 先必新, Sanbexin | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Cerebral Hemorrhage; Stroke; Ischemic Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Cognition Disorders | Details |
Adalimumab biosimilar (CTTQ Pharma) | TQZ-2301; TQZ2301 | Approved | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Mainland China | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 2022-01-18 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Crohn Disease | Details | |
Infliximab biosimilar (AXXO) | Approved | Axxo | Russian Federation | Crohn Disease; Autoimmune Diseases | Axxo | 2013-01-01 | Autoimmune Diseases; Crohn Disease | Details | ||
Infliximab biosimilar (Celltrion) | CT-P13 | Approved | Celltrion Inc | ZYMFENTRA, Remsima, Flammegis, Inflectra, Inflectra/Remsima | EU | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis; Arthritis, Psoriatic | Celltrion Healthcare Hungary Kft | 2013-09-10 | Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Crohn Disease; Plaque psoriasis | Details |
Adalimumab biosimilar (Zydus Cadila) | ZRC-3197 | Approved | Zydus Cadila | Exemptia, Adaly | India | Arthritis, Juvenile; Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing | Zydus Cadila | 2014-12-09 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Psoriatic | Details |
Ozoralizumab | PF-5230896; ATN-103; PF-05230896; TS-152 | Approved | Ablynx Nv | ナノゾラ, Nanozora | Japan | Arthritis, Rheumatoid | Taisho Pharmaceutical Co Ltd | 2022-09-26 | Arthritis, Rheumatoid | Details |
Opinercept | E-11; ENIA-11 | Approved | TSH Biopharm Corp Ltd, Mycenax Biotech Inc | TuNEX | Taiwan | Arthritis, Rheumatoid | null | 2017-01-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
Adalimumab biosimilar (Shilpa Biologicals) | SBDM-02 | Approved | Shilpa Biologicals Pvt Ltd | Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Crohn Disease; Plaque psoriasis | Details | |||||
Etanercept biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | Arthritis, Rheumatoid | Details | ||||||
Adalimumab biosimilar (Hisun Pharma) | HS-016 | Approved | Zhejiang Hisun Pharmaceutical Co Ltd | 安健宁 | Mainland China | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Hisun Biopharmaceutical Co Ltd | 2019-12-06 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
Infliximab biosimilar (Merck & Co/Samsung Bioepis) | SB-2 | Approved | Samsung Bioepis Co Ltd, Merck & Co Inc | Renflexis, Flixabi | EU | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis; Arthritis, Psoriatic | Samsung Bioepis Nl Bv | 2016-05-26 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis; Crohn Disease | Details |
Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
Edaravone/(+)-2-Decanol (Yantai Yene/Simcere) | Y-2 | Approved | Yantai Yene Pharma Co Ltd, Simcere Pharmaceutical Group Ltd | Mainland China | Stroke | Jiangsu Simcere Pharmaceutical Co Ltd | 2024-12-01 | Intracranial Hemorrhages; Stroke; Cognitive Dysfunction | Details | |
Adalimumab biosimilar (Coherus BioSciences) | CHS-1420 | Approved | Coherus Biosciences Inc | Yusimry | United States | Crohn Disease; Plaque psoriasis; Arthritis, Juvenile; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative | Coherus Biosciences Inc | 2021-12-17 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis | Details |
Infliximab biosimilar (Nichiiko/Aprogen) | NI-071; GS-071; GS-07; AP-07 | Approved | Nichi-Iko Pharmaceutical Co Ltd, Aprogen | Japan | Arthritis, Psoriatic; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis | Nichi-Iko Pharmaceutical Co Ltd | 2017-09-27 | Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details | |
Thalidomide | NSC-66847; NSC-527179; K-17; FPF-300; FPF300 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous; Multiple Myeloma | Changzhou Pharmaceutical Factory | 1982-01-01 | Xerostomia; Colorectal Neoplasms; Neuroectodermal Tumors, Primitive; Prostatitis; Primary Myelofibrosis; Osteosarcoma; Cholangitis, Sclerosing; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Adenocarcinoma, Clear Cell; Carcinoma, Adenosquamous; Epilepsy; Erythema Nodosum; Sarcoma; HIV Wasting Syndrome; Pancreatitis, Chronic; Sarcoma, Ewing; Arachnoiditis; Gastrointestinal Hemorrhage; Retinoblastoma; Prostatic Neoplasms; Endometriosis; Lung Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Vascular Malformations; Myelodysplastic-Myeloproliferative Diseases; Mycobacterium avium-intracellulare Infection; Amyotrophic Lateral Sclerosis; Carcinoma, Hepatocellular; Burning Mouth Syndrome; Stomatitis; Neoplasm Metastasis; Appendiceal Neoplasms; Tuberculosis; Lymphoma, Non-Hodgkin; Angiodysplasia; Pelvic Pain; Glioma; Waldenstrom Macroglobulinemia; Leprosy, Lepromatous; Endometrial Neoplasms; Uterine Neoplasms; Anemia, Sideroblastic; Ovarian Neoplasms; Gastric Antral Vascular Ectasia; Lupus Erythematosus, Discoid; Carc | Details |
Adalimumab biosimilar (Pfizer) | PF-06410293 | Approved | Pfizer Inc | Abrilada, Fyzoclad, Amsparity | United States | Crohn Disease; Psoriasis; Arthritis, Rheumatoid; Colitis, Ulcerative; Arthritis, Juvenile; Arthritis, Psoriatic; Spondylitis, Ankylosing | Pfizer Inc | 2019-11-15 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Crohn Disease | Details |
Etanercept biosimilar (Hisun-Pfizer Pharmaceuticals) | Approved | Hisun-Pfizer | AnBaiNuo, 安佰诺 | Mainland China | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Wyeth Europa Ltd | 2010-02-26 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | |
Adalimumab | ABT-D2E7; LU-200134; D2E7 | Approved | Abbvie Inc | Humira, Trudexa, 修美乐 | United States | Arthritis, Rheumatoid | Abbvie Inc | 2002-12-31 | Osteoarthritis; Periarthritis; Colitis, Ulcerative; Arthritis, Psoriatic; Cystitis, Interstitial; Asthma; Osteoarthritis, Knee; Hidradenitis Suppurativa; Uveitis; Arthritis; Glomerulosclerosis, Focal Segmental; Mucopolysaccharidosis II; Uveitis, Posterior; Nephrotic Syndrome; Diabetic Retinopathy; Crohn Disease; Plaque psoriasis; Panuveitis; Choroidal Neovascularization; Spondylitis, Ankylosing; Pyoderma Gangrenosum; Uveitis, Intermediate; Prostatic Hyperplasia; Pain; Arthritis, Rheumatoid; Sarcoidosis; Spondylarthritis; Coronavirus Disease 2019 (COVID-19); Non-radiographic axial spondyloarthritis; Pediatric Crohn's disease; Pouchitis; Arthritis, Juvenile; Mucopolysaccharidosis I; Nephrosis, Lipoid; Dupuytren Contracture; Psoriasis; Mucopolysaccharidosis VI | Details |
Etanercept biosimilar (Qilu Pharmaceutical) | QL-0902 | Approved | Qilu Pharmaceutical Co Ltd | Mainland China | Qilu Pharmaceutical Co Ltd | 2023-12-19 | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Details | ||
Etanercept biosimilar (Samsung Bioepis) | SB-4 | Approved | Samsung Bioepis Co Ltd | Eticovo, Benepali | EU | Arthritis, Psoriatic; Arthritis, Rheumatoid; Plaque psoriasis; Spondylitis, Ankylosing | Samsung Bioepis Nl Bv | 2016-01-13 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
Etanercept | TNR-001 | Approved | Amgen Inc, Pfizer Inc | Lifmior, 恩利, Enbrel | EU | Arthritis, Juvenile; Plaque psoriasis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Psoriatic | Pfizer Europe Ma Eeig | 2000-02-02 | Cachexia; Pulmonary Fibrosis; Temporomandibular Joint Disorders; Psoriasis; Myositis, Inclusion Body; Prostatic Neoplasms; Arthritis, Psoriatic; Asthma; Alzheimer Disease; Bone Neoplasms; Lichen Planus; Lung Neoplasms; Respiratory Distress Syndrome, Adult; Arthritis; Uveitis; Inflammation; Hidradenitis Suppurativa; Obesity; Stomatitis; Plaque psoriasis; Acute Lung Injury; Kidney Failure, Chronic; Neoplasm Metastasis; Vitiligo; Anorexia; Solid tumours; Tinnitus; Leukemia; Diabetes Mellitus, Type 1; Granulomatosis with Polyangiitis; HIV Infections; Bronchiolitis Obliterans; Lupus Erythematosus, Discoid; Rejection of lung transplantation; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Non-radiographic axial spondyloarthritis; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Synovitis; Metabolic Syndrome; Vasculitis; Spondylarthritis; Chronic Urticaria; Graft vs Host Disease; Fanconi Anemia; Arthritis, Juvenile | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Adalimumab biosimilar (Danhong Pharma) | BC-002 | Phase 3 Clinical | Shandong Danhong Pharmaceutical Co Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
Adalimumab biosimilar (Hetero Drugs) | Phase 3 Clinical | Hetero Drugs Ltd | Arthritis, Rheumatoid | Details | |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | HIV Infections; Hematopoietic stem cell transplantation (HSCT); Solid tumours; Leukemia; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Dyslipidemias; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Melanoma | Details |
Adalimumab biosimilar (CinnaGen) | Phase 3 Clinical | Cinnagen | Arthritis, Rheumatoid | Details | |
Adalimumab biosimilar (Hualan Biological Engineering) | Phase 3 Clinical | Hualan Genetic Engineering Co Ltd | Spondylitis, Ankylosing; Psoriasis; Arthritis | Details | |
Etanercept biosimilar (Clover Biopharmaceuticals) | SCB-808 | Phase 3 Clinical | Clover Biopharmaceuticals Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Thrombocytopenia | Details |
Golimumab biosimilar (Bio-thera) | BAT-2506 | Phase 3 Clinical | Bio-Thera Solutions Ltd | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Arthritis | Details |
Recombinant anti-TNFα monoclonal antibody (Wuhan Institute of Biological Products) | Phase 3 Clinical | Wuhan Institute Of Biological Products Co Ltd | Plaque psoriasis | Details | |
Adalimumab biosimilar (Tonghua Dongbao Pharmaceutical) | Phase 3 Clinical | Tonghua Dongbao Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Plaque psoriasis | Details | |
Adalimumab biosimilar (Enzene Biosciences) | Phase 3 Clinical | Enzene Biosciences Ltd | Spondylitis, Ankylosing | Details | |
Golimumab biosimilar (Reliance Life Sciences) | RTPR-044 | Phase 3 Clinical | Reliance Life Sciences | Arthritis, Rheumatoid | Details |
Tanfanercept | HBM-9036; HL-036 | Phase 3 Clinical | Hanall | Dry Eye Syndromes; Xerophthalmia | Details |
Adalimumab biosimilar (Trpharm) | Phase 3 Clinical | Trpharm | Arthritis, Rheumatoid | Details | |
Etanercept Biosimilar (Mabxience Holdings) | MB04; MB-04 | Phase 3 Clinical | Mabxience Holdings SL | Autoimmune Diseases; Arthritis, Rheumatoid | Details |
Adalimumab biosimilar (Mabscale) | Phase 3 Clinical | Mabscale LLC | Plaque psoriasis | Details | |
Adalimumab biosimilar(Incepta) | Phase 3 Clinical | Incepta Pharmaceuticals Ltd | Arthritis, Rheumatoid | Details | |
Hemay007 | Hemay-007 | Phase 2 Clinical | Tianjin Hemay Bio-Tech Co Ltd | Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative | Details |
Recombinant anti-TNFα monoclonal antibody (Livzon Group) | AT-132(Livzon Group); LZM-001 | Phase 2 Clinical | Livzon Pharmaceutical Group Inc | Arthritis, Rheumatoid | Details |
CC-10015 | CC-10015 | Phase 2 Clinical | Celgene Corp | Sarcoidosis; Multiple Myeloma; Lupus Erythematosus, Systemic | Details |
EYS-606 | EYS-606 | Phase 2 Clinical | Eyevensys SAS | Uveitis | Details |
Licaminlimab | OCS-02; ESBA-1622; LME-636 | Phase 2 Clinical | Oculis Pharma, Alcon | Dry Eye Syndromes; Uveitis, Anterior | Details |
XTMAB-16 | XTMAB-16 | Phase 2 Clinical | Xentria Inc | Sarcoidosis, Pulmonary | Details |
SOR-101 | SOR-101; SOR101 | Phase 2 Clinical | Sorriso Pharmaceuticals Inc | Colitis | Details |
SAR-441566 | SAR-441566 | Phase 2 Clinical | Sanofi | Arthritis, Rheumatoid; Psoriasis; Plaque psoriasis; Crohn Disease | Details |
SAR-442970 | SAR-442970 | Phase 2 Clinical | Sanofi | Nephrosis; Glomerulosclerosis, Focal Segmental; Hidradenitis Suppurativa; Inflammation; Glomerulonephritis | Details |
Guselkumab/Golimumab | JNJ-78934804 | Phase 2 Clinical | Janssen Research & Development Llc | Colitis, Ulcerative; Crohn Disease | Details |
Isomyosamine | MYMD-1 | Phase 2 Clinical | Mymd Pharmaceuticals Inc | Anxiety; Frailty; Hashimoto Disease; Depression; Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Healthy Aging; Inflammation; Sarcopenia | Details |
ME-3183 | ME-3183 | Phase 2 Clinical | Meiji Seika Pharma Co Ltd | Psoriasis; Plaque psoriasis | Details |
OPS-2071 | OPS-2071 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd | Enteritis; Irritable Bowel Syndrome; Crohn Disease | Details |
Adalimumab biosimilar (Eastern Biotech) | JY-026 | Phase 1 Clinical | Beijing Eastern Biotech Co Ltd | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Crohn Disease | Details |
Recombinant human anti-TNFα monoclonal antibody (Qilu Pharmaceutical) | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Details | |
Recombinant human monoclonal antibody specific for human tumor necrosis factor (North China Pharmaceutical) | Phase 1 Clinical | North China Pharmaceutical Company Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details | |
Certolizumab (Intrexon) | AG-014 | Phase 1 Clinical | Intrexon Corporation | Inflammatory Bowel Diseases | Details |
Adalimumab biosimilar (Weimingdamu Biotech) | Phase 1 Clinical | Anhui Weiming Damu Biomedicine Co Ltd | Arthritis, Rheumatoid | Details | |
Anti-tumour necrosis factor alpha (Livzon) | Phase 1 Clinical | Livzon Pharmaceutical Group Inc | Autoimmune Diseases | Details | |
SFA-002 | SFA-002; SFA002 | Phase 1 Clinical | Arthritis, Rheumatoid; Plaque psoriasis | Details | |
Etanercept biosimilar (Suzhou Genemen Biotech) | BF-02; GM-02 | Phase 1 Clinical | Suzhou Genemen Biotech Co Ltd | Spondylitis, Ankylosing | Details |
Infliximab biosimilar (Ospedale San Raffaele) | Phase 1 Clinical | Ospedale San Raffaele | Takayasu Arteritis | Details | |
Dovramilast | CC-11050; AMG-634 | Phase 1 Clinical | Celgene Corp | HIV Infections; Lupus Erythematosus, Cutaneous; Tuberculosis | Details |
Recombinant anti-TNFα antibody (Shanghai Xiesheng Medicine) | Phase 1 Clinical | Shanghai Harmony Pharmaceutical Technology Co Ltd | Details | ||
JNJ-61178104 | JNJ-61178104 | Phase 1 Clinical | Johnson & Johnson Innovative Medicine | Autoimmune Diseases | Details |
Adalimumab biobetter (Xencor/Zenas Biopharma) | Xtend-TNF; XmAb-6755; ZB-002 | Phase 1 Clinical | Xencor Inc | Arthritis, Rheumatoid; Autoimmune Diseases of the Nervous System | Details |
JNJ-63823539 | JNJ-63823539 | Phase 1 Clinical | Johnson & Johnson Innovative Medicine | Arthritis, Rheumatoid | Details |
Etanercept biosimilar (Shilpa Biologicals) | SBDM-01 | Phase 1 Clinical | Shilpa Biologicals Pvt Ltd | Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Plaque psoriasis | Details |
SAR-444970 | SAR444970; SAR-444970 | Phase 1 Clinical | Sanofi | Inflammation | Details |
Adalimumab biosimilar (Laboratorios Richmond) | Phase 1 Clinical | Laboratorios Richmond | Details | ||
NEX-20A | NEX-20A | Phase 1 Clinical | Nanexa AB | Multiple Myeloma | Details |
IA-14069 | IA-14069 | Phase 1 Clinical | ILAb Co Ltd | Arthritis, Rheumatoid | Details |
SOR-102 | SOR-102 | Phase 1 Clinical | Sorriso Pharmaceuticals Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative | Details |
Monoclonal Antibody (Mab) sB24M | Phase 1 Clinical | Swiss Biopharma Med GmbH | Pyoderma Gangrenosum; Pyoderma | Details | |
ND-009 | ND-009 | Phase 1 Clinical | Numab Therapeutics Ag, Tillotts Pharma Ag | Inflammation | Details |
Adalimumab biosimilar (DZM Biotech) | Phase 1 Clinical | Dzm Biotech Ltd | Arthritis, Rheumatoid | Details | |
Igrelimogene litadenorepvec | PM-1016; PM1016; TILT-123 | Phase 1 Clinical | Tilt Biotherapeutics Ltd | Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular; Melanoma | Details |
Adalimumab biosimilar (Prestige BioPharma) | PBP-1502 | Phase 1 Clinical | Prestige BioPharma Ltd | Details | |
Adalimumab biosimilar (AXXO) | Clinical | Axxo | Arthritis, Rheumatoid; Arthritis, Psoriatic | Details | |
IBPM005IX (Inbiopro Solutions) | Clinical | Inbiopro Solutions | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Arthritis, Psoriatic; Crohn Disease | Details | |
Etanercept (Neurokine Pharmaceuticals) | NP-1; NK-001 | Clinical | Pivot Pharmaceuticals | Cognition Disorders | Details |
Adalimumab biosimilar(BioXpress) | BX-2922; BXT-2922 | Clinical | Bioxpress Therapeutics Sa | Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Rheumatoid; Arthritis, Juvenile; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Hidradenitis Suppurativa; Crohn Disease | Details |
Wogonin | Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University | Details |
This web search service is supported by Google Inc.